Clinical Trial: Predictive value of glycocalyx injury markers in thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation in severe aplastic anemia (China)

Posted On: 2026-10-22

China, Oct. 22 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Predictive value of glycocalyx injury markers in thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation in severe aplastic anemia'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134821

Registration Time: 2026/10/21

Type: Observational study

Primary Sponsor: Guabgzhou First People‘s Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344326

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Predictive value of glycocalyx injury markers in thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation in severe aplastic anemia (China)